HTL0039732 in Participants With Advanced Solid Tumours — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

HTL0039732 in Participants With Advanced Solid Tumours — Stella

Home/Neoplasms/

View on ClinicalTrials.gov

Recruiting

Back to Neoplasms trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(5 sites)

United Kingdom

Addenbrooke's Hospital, Cambridge

Velindre Cancer Centre, Cardiff

Clatterbridge Cancer Centre, Liverpool

Guy's Hospital, London

The Christie Hospital, Manchester

Key details

Phase

Early testing / Safety & dosing

Sponsor

Cancer Research UK

Collaborators

Nxera Pharma UK Limited

Enrollment target

~150 participants

Started

July 2023

Primary completion

June 2027

Age range

18 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.